Zenas BioPharma Announces Positive Results from Phase 2 MoonStone Trial Zenas BioPharma, a clinical-stage global biopharmaceutical company, announced positive results from the Phase 2 Moon…
Potential Human Pandemic from H9N2 Bird Flu Strain A recent study suggests that the H9N2 bird flu strain, often considered minor, has adap…
Fixing Intel Foundry Is Like Stopping Tripping Down The Stairs Technical debt is a real thing, as any IT manager, programmer, system admin…
RingCentral Recognized as a Leader in 2025 Gartner Magic Quadrant RingCentral, Inc. has been named a Leader in the 2025 Gartner Magic Quad…
Assessing the Success of Salt Lake City's 'No Kings' Protest The second "No Kings" protest in Salt Lake City has concluded, and organizers…
Finding Efax Alternatives for Small Businesses As the world of business communication evolves, small businesses seek efficient and cost-ef…
Community Pharmacies and BioPharma: Advancing Whole-Patient Care Together The healthcare landscape has never been more complex, with an ag…
ASX Market Update The Australian stock exchange (ASX) is experiencing a decline, led by heavy falls in the healthcare and tech sectors, de…
Physician Attrition Rates on the Rise A recent study has found that physician attrition from clinical practice has increased since 2013.
OMNOM To Open a Second Site in Birmingham This November, OMNOM, a celebrated vegetarian and vegan restaurant and wellness charity from Isl…
A Seemingly ‘Harmless’ Shark Species Killed a Swimmer in First-Ever Instance — and Experts Know Why The incident unfolded in April 2025, w…